For the quarter ending 2025-09-30, RGEN has $2,923,711K in assets. $840,624K in debts. $748,747K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 748,747 | 708,855 | ||
| Accounts receivable, net of reserves of 2,274 and 1,832 at september 30, 2025 and december 31, 2024, respectively | 148,970 | 156,952 | ||
| Inventories, net | 160,320 | 155,862 | ||
| Prepaid expenses and other current assets | 38,448 | 35,196 | ||
| Total current assets | 1,096,485 | 1,056,865 | ||
| Property, plant and equipment, net | 188,927 | 193,489 | ||
| Intangible assets, net | 395,442 | 406,213 | ||
| Goodwill | 1,112,735 | 1,114,009 | ||
| Deferred tax assets | 856 | 800 | ||
| Operating lease right of use assets | 124,161 | 127,682 | ||
| Other noncurrent assets | 5,105 | 2,569 | ||
| Total noncurrent assets | 1,827,226 | 1,844,762 | ||
| Total assets | 2,923,711 | 2,901,627 | ||
| Accounts payable | 29,426 | 25,625 | ||
| Operating lease liabilities | 19,314 | 16,043 | ||
| Contingent consideration | 5,107 | 5,168 | ||
| Accrued liabilities | 77,289 | 76,176 | ||
| Total current liabilities | 131,136 | 123,012 | ||
| Convertible senior notes due 2028, net | 537,927 | - | ||
| Deferred tax liabilities | 20,135 | 23,326 | ||
| Convertible senior notes due 2028, net | - | 533,725 | ||
| Noncurrent operating lease liabilities | 131,626 | 136,296 | ||
| Noncurrent contingent consideration | 2,478 | 6,658 | ||
| Other noncurrent liabilities | 17,322 | 16,869 | ||
| Total noncurrent liabilities | 709,488 | 716,874 | ||
| Total liabilities | 840,624 | 839,886 | ||
| Common stock, 0.01 par value 80,000,000 shares authorized 56,283,321 shares at september 30, 2025 and 56,091,677 shares at december 31, 2024 issued and outstanding | 563 | 563 | ||
| Additional paid-in capital | 1,643,670 | 1,634,844 | ||
| Accumulated other comprehensive loss | -4,107 | -1,716 | ||
| Retained earnings | 442,961 | 428,050 | ||
| Total stockholders' equity | 2,083,087 | 2,061,741 | ||
| Total liabilities and stockholders' equity | 2,923,711 | 2,901,627 | ||
REPLIGEN CORP (RGEN)
REPLIGEN CORP (RGEN)